Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of myRAteam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

My insurance is no longer covering Humira and I normally take Humira with methotrexate and Tylenol or ibuprofen as needed for pain.

April 5, 2024
 · 
Reactions
A myRAteam Member

Thank you so much for the answer. I saw all of these positive posts about embrel and wondered if I should’ve researched a different biologic but I’m hoping starting my Hyromiz will be positive thank you

April 9, 2024
A myRAteam Member

I recently switched from Humira to Hyrimoz due to insurance, too. I haven't noticed a difference except I no longer get injection site reactions like I did with Humira.

April 8, 2024
myRAteam

Yes, some individuals with moderate to severe rheumatoid arthritis have switched from Humira (adalimumab) to Hyrimoz (adalimumab-adaz), which is a biosimilar to Humira. Hyrimoz is used as targeted therapy for rheumatoid arthritis and works by blocking the activity of tumor necrosis factor (TNF), a substance that can cause Show Full Answer

Yes, some individuals with moderate to severe rheumatoid arthritis have switched from Humira (adalimumab) to Hyrimoz (adalimumab-adaz), which is a biosimilar to Humira. Hyrimoz is used as targeted therapy for rheumatoid arthritis and works by blocking the activity of tumor necrosis factor (TNF), a substance that can cause inflammation and contribute to the symptoms of rheumatoid arthritis. It's taken every other week via subcutaneous injection. People might consider switching to a biosimilar like Hyrimoz for various reasons, including cost considerations or insurance coverage changes. It's important to discuss any potential switch with a healthcare provider, considering factors like efficacy, safety, and how the body might respond to a different formulation.

April 5, 2024

Related Questions

View All